NCT03203252

Brief Summary

Measuring appearance of implant-based breast reconstruction after mastectomy for breast cancer - an online approach to research. Using 3-dimensional surface images we intend to create a tool to measure appearance after surgery in order to improve standards of care for women. We want to minimise the number of visits and amount of time involved in research participation so this pilot study will develop new online tools for information giving and gathering, and for consent so that only one visit to hospital will be required for photographs. This will also extend the availability of expensive 3D technology to more women.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2017

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 15, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2017

Completed
Last Updated

June 29, 2017

Status Verified

June 1, 2017

Enrollment Period

3 months

First QC Date

June 15, 2017

Last Update Submit

June 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recruitment Rate to a study of this design

    The study team will assess the number of participants as a proportion of those approached. The study team will assess the proportion of those approached versus those who complete the recruitment process by attending for their 3D-SI.

    3 months

Secondary Outcomes (7)

  • To understand dropout rates

    6 months

  • To understand how long it takes to complete the online recruitment process.

    6 months

  • To understand reasons for not completing the online process once started.

    6 months

  • To analyse how accurately participants report data pertaining to their medical treatment and themselves (eg height and weight/use of radiotherapy)

    6 months

  • To assess inter- and intra-observer variability in a range of objective measurements to enable us to choose those to measure in the multi-centre study.

    6 months

  • +2 more secondary outcomes

Interventions

Validated Patient reported outcome measure specifically designed to assess Quality of life domains and satisfaction following breast reconstruction.

Non-invasive 3-dimensional photograph using VECTRA® XT 3D imaging system.

Online questionnaire pertaining to treatment received pertaining to breast cancer or risk reduction for breast cancer.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is an observational study of female participants who have undergone mastectomy and implant-based reconstruction within the last 1-5 years. The research will be carried out at the Royal Marsden NHS Foundation Trust Sutton.

You may qualify if:

  • Female patients
  • Over 18 years
  • Have undergone implant-based reconstruction 1-5 years before study entry (can be unilateral or bilateral, immediate or delayed, nipple-sparing or nipple-sacrificing, risk reducing or therapeutic)

You may not qualify if:

  • \<1 year or over 5 years from surgery
  • Explantation
  • Local or distant recurrence
  • Lacks capacity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Marsden Hospital

Sutton, Surrey, sm25pt, United Kingdom

RECRUITING

Related Publications (3)

  • Pusic et al. Measuring Quality of Life in Breast Surgery: Content development of a new modular system to capture patient reported outcomes (The MSKCC BREAST-Q). ISOQOL Annual Meeting. October 2006 Lisbon, Portugal

    BACKGROUND
  • Pusic AL, Chen CM, Cano S, Klassen A, McCarthy C, Collins ED, Cordeiro PG. Measuring quality of life in cosmetic and reconstructive breast surgery: a systematic review of patient-reported outcomes instruments. Plast Reconstr Surg. 2007 Sep 15;120(4):823-837. doi: 10.1097/01.prs.0000278162.82906.81.

  • Godden AR, Wood SH, James SE, MacNeill FA, Rusby JE. A scoring system for 3D surface images of breast reconstruction developed using the Delphi consensus process. Eur J Surg Oncol. 2020 Sep;46(9):1580-1587. doi: 10.1016/j.ejso.2020.05.016. Epub 2020 Jun 7.

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Jennifer E Rusby, BMBS, MD

CONTACT

Amy R Godden, MBBS, BSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2017

First Posted

June 29, 2017

Study Start

June 9, 2017

Primary Completion

August 30, 2017

Study Completion

August 30, 2017

Last Updated

June 29, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations